// App-Quantinova.ai

EP994 : EFFECTIVENESS AND SAFETY OF IXAZOMIB-BASED THERAPY IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (MM) OUTSIDE OF A CLINICAL TRIAL: FINAL ANALYSIS OF THE ‘USE VIA EARLY ACCESS TO IXAZOMIB’ (UVEA IXA) STUDY

Researchers

Presenter

  • Heinz Ludwig

Principal Investigators

  • Evangelos Terpos

  • Mara-Victoria Mateos

  • Mario Boccadoro

  • Bhuvan Kishore

  • Karthik Ramasamy

  • Petra Krhovska

  • Matthew Streetly

  • Miriam Ladicka

  • Sylvie Fernandez

  • Lucia Simoni

  • Nawal Bent-Ennakhil

  • Athanasios Zomas

  • Francois Gavini

  • Roman Hjek

Medical Centers

  • 7MediNeos Observational Research Modena Italy

  • Department of Hematology,University Hospital of Salamanca, IBSAL, CIC, IBMCC (USAL-CSIC),Salamanca,Spain

  • Division of Hematology, University of Turin, Turin, Italy

  • Oxford University Hospitals NHS Trust, Oxford, United Kingdom

  • Guy's And St Thomas NHS Foundation Trust, London, United Kingdom

  • Faculty of Medicine Department of Internal Medicine and Haematology, Semmelweis University,Budapest,Hungary

  • Department of Haematooncology, University Hospital Ostrava and the Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic

  • Dept. of Hematology/Oncology, Charles University Hospital, Pilsen, Czech Republic,

  • Dept. of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens, Athens, Greece

  • National Cancer Institute, Bratislava, Slovakia

  • University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom

  • Takeda Pharmaceutical International AG, Zürich, Switzerland

  • Wilhelminen Cancer Research Institute, Department of Medicine I, Center for Oncology, Hematology and Palliative Care, Wilhelminen Hospital, Vienna, Austria

Locations

  • Italy

  • Spain

  • United Kingdom

  • Hungary

  • Czech Republic

  • Greece

  • Slovakia

  • Switzerland

  • Austria

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • N/A

Drug/Treatment

  • Lenalidomide

  • Ixazomib

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved